|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0009566,
umls-concept:C0010181,
umls-concept:C0013554,
umls-concept:C0019139,
umls-concept:C0040508,
umls-concept:C0041703,
umls-concept:C0043031,
umls-concept:C0149871,
umls-concept:C0199176,
umls-concept:C0206460,
umls-concept:C0332281,
umls-concept:C0443252,
umls-concept:C0543467,
umls-concept:C1274040,
umls-concept:C1516048
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2002-12-27
|
|
pubmed:abstractText |
Premature death due to pulmonary embolism is a short-term complication of deep vein thrombosis (DVT). The long-term clinical course after DVT can be further complicated by excess mortality, recurrent venous thromboembolism (VTE), and the post-thrombotic syndrome (PTS), which may produce sizable long-term economic burdens.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0149-2918
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
24
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1960-86; discussion 1938
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12501885-Aged,
pubmed-meshheading:12501885-Aged, 80 and over,
pubmed-meshheading:12501885-Anticoagulants,
pubmed-meshheading:12501885-Arthroplasty, Replacement, Hip,
pubmed-meshheading:12501885-Cost-Benefit Analysis,
pubmed-meshheading:12501885-Drug Costs,
pubmed-meshheading:12501885-Enoxaparin,
pubmed-meshheading:12501885-Female,
pubmed-meshheading:12501885-Humans,
pubmed-meshheading:12501885-Male,
pubmed-meshheading:12501885-Models, Economic,
pubmed-meshheading:12501885-Monte Carlo Method,
pubmed-meshheading:12501885-Postoperative Complications,
pubmed-meshheading:12501885-Quality of Life,
pubmed-meshheading:12501885-Recurrence,
pubmed-meshheading:12501885-United States,
pubmed-meshheading:12501885-Venous Thrombosis,
pubmed-meshheading:12501885-Warfarin
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Results of an economic model to assess the cost-effectiveness of enoxaparin, a low-molecular-weight heparin, versus warfarin for the prophylaxis of deep vein thrombosis and associated long-term complications in total hip replacement surgery in the United States.
|
|
pubmed:affiliation |
International Health Economics, HERQuLES, Abt Associates Clinical Trials, Bethesda, Maryland 20814, USA. marc_botteman@abtassoc.com
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
